Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

Item
http://www.wikidata.org/entity/Q34084735
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressantsFunctioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaAssessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.Frequency and outcomes of painful physical symptoms in a naturalistic population with major depressive disorder: an analysis of pooled observational studies focusing on subjects aged 65 years and over.Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study.Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.Assessment and management of sexual dysfunction in the context of depression.Does G2677T Polymorphism of the MDR1 Gene Make a Difference in the Therapeutic Response to Paroxetine in Depressed Patients in a Slovakian Population?Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
P2860

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

Item
http://www.wikidata.org/entity/Q34084735
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Frequency of treatment-emergen ...... a 6-month observational study.
@ast
Frequency of treatment-emergen ...... a 6-month observational study.
@en
Frequency of treatment-emergen ...... a 6-month observational study.
@nl
type
label
Frequency of treatment-emergen ...... a 6-month observational study.
@ast
Frequency of treatment-emergen ...... a 6-month observational study.
@en
Frequency of treatment-emergen ...... a 6-month observational study.
@nl
prefLabel
Frequency of treatment-emergen ...... a 6-month observational study.
@ast
Frequency of treatment-emergen ...... a 6-month observational study.
@en
Frequency of treatment-emergen ...... a 6-month observational study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Frequency of treatment-emergen ...... a 6-month observational study.
@en
P2093
P2860
P304
P31
P356
10.3109/13651501.2011.572169
P433
P478
P50
P577
P5875
P698